A PHP Error was encountered

Severity: Warning

Message: mysqli::real_connect(): (08004/1040): Too many connections

Filename: mysqli/mysqli_driver.php

Line Number: 201

Backtrace:

File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/core/MY_Controller.php
Line: 10
Function: database

File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/libraries/WS_Controller.php
Line: 8
Function: __construct

File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/controllers/Search.php
Line: 8
Function: __construct

File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/index.php
Line: 329
Function: require_once



A PHP Error was encountered

Severity: Warning

Message: mysqli::real_connect(): (HY000/1040): Too many connections

Filename: mysqli/mysqli_driver.php

Line Number: 201

Backtrace:

File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/models/Home_model.php
Line: 7
Function: database

File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/libraries/WS_Controller.php
Line: 11
Function: model

File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/controllers/Search.php
Line: 8
Function: __construct

File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/index.php
Line: 329
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: mysqli::real_connect(): (HY000/1040): Too many connections

Filename: mysqli/mysqli_driver.php

Line Number: 201

Backtrace:

File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/models/News_model.php
Line: 7
Function: database

File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/libraries/WS_Controller.php
Line: 12
Function: model

File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/controllers/Search.php
Line: 8
Function: __construct

File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/index.php
Line: 329
Function: require_once

 Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 47

Results For "API"

2557 News Found

Biocon Academy conducts 9th Graduation Day
News | March 04, 2025

Biocon Academy conducts 9th Graduation Day

Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations


Venus Remedies secures firstiInternational market authorization for Sugammadex from the Philippines
Drug Approval | March 04, 2025

Venus Remedies secures firstiInternational market authorization for Sugammadex from the Philippines

The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations


Lilly plans to more than double US manufacturing investment since 2020 exceeding $50 billion
News | March 03, 2025

Lilly plans to more than double US manufacturing investment since 2020 exceeding $50 billion

Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America


PMBJP has led to a total savings of Rs. 30,000 crore for citizens: Health Minister Nadda
Policy | March 03, 2025

PMBJP has led to a total savings of Rs. 30,000 crore for citizens: Health Minister Nadda

In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025


WuXi XDC and LigaChem Biosciences expands MoU to accelerate ADC development
News | March 03, 2025

WuXi XDC and LigaChem Biosciences expands MoU to accelerate ADC development

WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs


Healthcare Triangle announces $15.2 million PIPE offering
News | March 01, 2025

Healthcare Triangle announces $15.2 million PIPE offering

The PIPE offering consists of 36,190,476 units


Lupin secures a place in S&P Global Sustainability Yearbook 2025
Sustainability | February 28, 2025

Lupin secures a place in S&P Global Sustainability Yearbook 2025

Yearbook members are selected basis their S&P Global 2024 Corporate Sustainability Assessment score


Briefs: Emcure and Relonchem
Drug Approval | February 27, 2025

Briefs: Emcure and Relonchem

USFDA inspection at Emcure Pharmaceuticals API facility


Venus Remedies secures in-licensing rights from Infex Therapeutics to develop and commercialize MET-X in India
News | February 27, 2025

Venus Remedies secures in-licensing rights from Infex Therapeutics to develop and commercialize MET-X in India

MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies